← SynDRA
PRAVASTATIN
SynDRA canonical compound SYN0004074 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | HMGCR |
|---|
| Mechanism of action | HMGCR inhibitor |
|---|
| Indication | hypercholesterolemia | hyperlipidemia | myocardial infarction |
|---|
| Disease area | cardiology | endocrinology |
|---|
All known targets
Mechanisms of action (all sources)
- HMGCR INHIBITOR
- HMG-CoA reductase inhibitor
Drug classes
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- HMG-CoA Reductase Inhibitor
- Anticholesteremic Agents
- Antimetabolites
- Enzyme Inhibitors
- Hypolipidemic Agents
- Lipid Regulating Agents
ATC classes
- C10A · LIPID MODIFYING AGENTS, PLAIN
- LIPID MODIFYING AGENTS, COMBINATIONS
Cross-references
Synonyms
- eptastatin
- mevalothin
- pravastatin acid
- pravastatin sodium
- pravachol
- Pravastatine
- Pravastatina
- Pravator
- C10AA03
- Eptastatin
- Oliprevin
- Pravastatinum
- Vasten
- Pravastatin Sodium Salt
- Pravastatina [Spanish]
- Pravastatine [French]
- Pravastatinum [Latin]
- KS-5015
- Pravachol (TN)
- Pravastatin (INN)
- Pravastatin [INN:BAN]
- Pravastatin tert-Octylamine Salt
- Pravator (TN)
- RMS-431
- Selektine (TN)
- SQ-31,000
- (3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid
- (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid
- 1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, (1S-(1alpha(betaS*,deltaS*),2alpha,6alpha,8beta(R*),8aalpha))-1-Naphthaleneheptanoic acid
- KXO2KT9N0G
- CHEBI:63618
- Pravastatinum (Latin)
- Apo Pravastatin
- Lin Pravastatin
- Nu Pravastatin
- RefChem:56363
- DTXCID003498
- RMS431
Reported adverse events
- Hypersensitivity
- Cough
- Headache
- Myalgia
- Myopathy
- Rash
- Vomiting
- Dizziness
- Fatigue
- Nausea
- Stevens-Johnson syndrome
- Influenza
Look up PRAVASTATIN in the interactive SynDRA portal →